Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Orthopedic pillow OEM solutions Thailand

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Indonesia custom insole OEM supplier

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Soft-touch pillow OEM service in Thailand

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.One-stop OEM/ODM manufacturing factory and solution provider

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.High-performance insole OEM China

Researchers have discovered a cellular uptake pathway that is crucial for larger molecules. These molecules can be used to create new drugs for treating cancer and other diseases as they bind in unique ways to their targets and are efficiently taken up by cells. Revolutionary Bitopic Inhibitors Pave the Way for Innovative Disease Treatment Strategies The development of drugs is a balancing act between making sure the drug is a good fit for its target and ensuring it can penetrate the cell membrane to reach that target. Typically, the search for drugs that can cross the cell membrane has focused on small, rigid molecules with nonpolar chemical structures. However, new therapeutic strategies break traditional drug design rules by employing larger, flexibly linked chemical entities. Recently, a team of researchers from the University of California, San Francisco (UCSF) published a study in Science, where they unveiled a new discovery of a cellular uptake pathway that is crucial for larger molecules. These large, complex molecules bind in unique ways to their targets, are efficiently taken up by cells, and have the potential to be used in creating new drugs for the treatment of cancer and other diseases. Through a combination of functional genomics and chemical methods, the scientists uncovered an endogenous pathway involving interferon-induced transmembrane (IFITM) proteins that promote the cellular uptake of diverse linked chemotypes. These proteins are found in plasma membranes and often provide cellular resistance to viruses. Challenges in Traditional Drug Targeting Most traditional pharmaceuticals are small molecules that follow simple molecular rules including limits on the molecular size and number of sticky chemical groups on the molecule’s surface. Many key drug targets, such as kinase enzymes often involved in cancer, are difficult to selectively target with traditional drugs. “There are over 500 human kinase enzymes that are very similar in the pocket where the drug binds, making it a challenge to selectively target a single member of this family and leading to undesirable medication side effects,” explains the study’s first author Kevin Lou. “Increasingly, it has been found that certain linked molecules outside this traditional framework can maintain drug-like properties and gain new mechanisms of action.” There are many important intracellular drug targets that researchers have been unable to target with small, compact, and rigid molecules. To address this challenge, scientists have taken to linking multiple ligands into a single chemical entity (a linked chemotype). These linked chemotypes can have enhanced potency, greater selectivity, and the capacity to induce the association of more than one target. “Given this discrepancy between the favorable biological activity of many large, bivalent molecules and traditional concepts of passive permeability, we inferred that linked chemotypes might hijack cellular processes to assist with passage through the cell membrane,” wrote Lou. We selected as an example a bitopic inhibitor of mTOR, RapaLink-1, whose molecular weight falls well beyond common guidelines.” Designing Multi-Pronged Inhibitors The team designed two new linked drugs that they hypothesized might take advantage of this cellular entry pathway. They generated DasatiLink-1 through a linker-joined combination of two known inhibitors of the leukemia protein BCL-ABL1, known as dasatinib and asciminib. Since each drug binds a distinct pocket on the target protein, the researchers reasoned that the linked version could affix itself to two points of contact like a two-pronged key inserting into two locks, enhancing its specificity and effectiveness. They also designed BisRoc-1 by linking two molecules of the chemotherapy drug rocaglamide together in a way that would allow it to bridge two copies of the drug’s protein target. Despite the fact that both of these drugs violate traditional drug design principles, the team showed that both drugs enter cells, bind tightly to their intended targets, and work just as well as the unlinked versions. The linked versions were uniquely dependent on IFITM protein expression in the target cells, supporting a general role for the IFITM pathway across many types of linked molecules. The researchers showed that DasatiLink-1 is specific for only the BCL-ABL1 kinase, unlike the more relaxed specificity of its two constituent drugs when unlinked. Advantages of Selectivity and Efficiency “Linked inhibitors that require a multi-pronged binding mechanism are much more selective,” Lou explains. “They offer substantial advantages as long as they can enter cells efficiently.” “We discovered that IFITM proteins enable bitopic inhibitors to enter cells and this will likely allow us to target previously untargetable proteins in disease,” said Luke Gilbert, Ph.D., co-corresponding author and the Goldberg-Benioff Endowed Professorship in Prostate Cancer Translational Biology at UCSF. “Hopefully, our study will generate new clues for how IFITM proteins function mechanistically that can be pursued by drug design scientists and virologists.” The scientists are working on chemically optimizing the properties of the linked BCR-ABL inhibitors to increase their potency and position them as next-generation therapeutics for BCR-ABL mutant cancers. “We are also excited to expand the scope of intracellular targets amenable to bitopic inhibition,” said Gilbert. Reference: “IFITM proteins assist cellular uptake of diverse linked chemotypes” by Kevin Lou, Douglas R. Wassarman, Tangpo Yang, YiTing Paung, Ziyang Zhang, Thomas A. O’Loughlin, Megan K. Moore, Regina K. Egan, Patricia Greninger, Cyril H. Benes, Markus A. Seeliger, Jack Taunton, Luke A. Gilbert and Kevan M. Shokat, 8 December 2022, Science. DOI: 10.1126/science.abl5829 The study was funded by the National Institutes of Health, the Damon Runyon Cancer Foundation, the Pew-Stewart Scholars program, the Goldberg-Benioff Endowed Professorship, the Howard Hughes Medical Institute, the Samuel Waxman Cancer Research Foundation, Wellcome Trust, the Ono Pharma Foundation, Pfizer, and Arc Institute.

A new breakthrough strategy strengthens CRISPR editing, minimizing large deletions and enhancing safety and accuracy in genetic modifications. Credit: 2024 KAUST KAUST researchers have improved CRISPR gene editing safety by reducing harmful DNA deletions and enhancing repair mechanisms, advancing towards safer genetic treatments. A simple and robust strategy developed by KAUST scientists could help to improve the safety and accuracy of CRISPR gene editing, a tool that is already approved for clinical use for the treatment of inherited blood disorders. This approach tackles a critical issue with CRISPR technology: the act of slicing the genome at specific points and then rejoining it, which inherently risks damaging the DNA in a manner that might cause large-scale and unpredictable disruptions. Hoping to mitigate this issue, a team led by Mo Li, a stem cell biologist at KAUST, investigated DNA repair pathways that lead to large genomic deletions following CRISPR editing in human stem cells. Their analysis led them to a process known as microhomology-mediated end joining (MMEJ), an error-prone mechanism that, although capable of fixing breaks in DNA, often leaves behind large deletions in its wake. Key Genetic Findings The scientists interrogated various genes implicated in this MMEJ process and found two that played central — but opposing — roles in these unwanted deletion events. One gene, called POLQ, turned out to exacerbate the risk of large deletions following CRISPR editing. The other, called RPA, emerged as a genomic guardian with protective effects. By manipulating these genes, either with drugs that inhibit POLQ or through genetic techniques that boost the expression of RPA, the KAUST team was then able to reduce the occurrence of detrimental large deletions without compromising the efficiency of genome editing and, in so doing, preserve the genomic integrity of edited stem cells. “This easy-to-use approach could reduce the chances of these harmful large DNA deletions from happening,” says Baolei Yuan, a former Ph.D. student in Li’s lab and one of the architects of the study, along with Chongwei Bi and Yeteng Tian from Li’s lab. Enhancing Repair Mechanisms Moreover, these same interventions were found to enhance the efficiency of homology-directed repair, a mechanism known for its ability to enable accurate genome editing without adding unintended mutations. This was evident in experiments involving stem cells that carried mutations in two genes linked to sickle cell disease and Wiskott-Aldrich Syndrome, both inherited blood disorders. By modulating POLQ or RPA, the researchers achieved highly precise and reliable gene editing in these cells. The findings mark a significant step forward in refining CRISPR technology, asserts Li. “It’s really exciting because it means we’re getting closer to safer and more effective treatments for genetic diseases,” he says. With a provisional patent application filed for this innovative strategy, the team continues to explore the mechanisms behind a wider array of undesirable mutations and to hone its techniques for making CRISPR safer and more efficient. “Achieving both high efficiency and safety remains a challenge that requires further development,” Li says, “and our laboratory remains at the forefront, seeking out novel solutions.” Reference: “Modulation of the microhomology-mediated end joining pathway suppresses large deletions and enhances homology-directed repair following CRISPR-Cas9-induced DNA breaks” by Baolei Yuan, Chongwei Bi, Yeteng Tian, Jincheng Wang, Yiqing Jin, Khaled Alsayegh, Muhammad Tehseen, Gang Yi, Xuan Zhou, Yanjiao Shao, Fernanda Vargas Romero, Wolfgang Fischle, Juan Carlos Izpisua Belmonte, Samir Hamdan, Yanyi Huang and Mo Li, 29 April 2024, BMC Biology. DOI: 10.1186/s12915-024-01896-z

Chronic stress may dull our perception of everyday sounds by rewiring the brain’s response to noise. Chronic stress does more than just affect mood—it may actually change the way we hear. Researchers found that stressed mice needed louder sounds to trigger normal brain responses. This shift seems to be linked to certain brain cells becoming overly active while others are suppressed, altering how sounds are processed. Their findings suggest that long-term stress doesn’t just heighten our emotional responses but may also dampen our ability to perceive neutral sounds, which could have implications for sensory processing disorders and mental health. Chronic Stress Alters How We Hear Sounds Chronic stress can change the way the brain processes sound, according to new research on mice at Ben-Gurion University of the Negev. The study found that under prolonged stress, the brain requires louder sounds to produce the same response as before. While chronic stress is known to affect learning and decision-making, its impact on hearing has been less explored. Dr. Jennifer Resnik from Ben-Gurion University’s Department of Life Sciences set out to investigate whether stress alters basic brain functions, including how we process sounds. “We know that chronic stress is a risk factor for several psychiatric and sensory disorders. However, there is little research on how our brains process neutral sounds under chronic stress,” she explains. Her findings were published today (February 11) in PLOS Biology. Investigating the Brain, Not the Ear Dr. Resnik’s research didn’t focus on how stress affects the ear itself. Instead, her team examined how chronic stress changes auditory processing in the brain, using mice to uncover how stress might alter the way sounds are interpreted. They discovered a clear effect of chronic stress on sound responses over time. Sounds at lower decibel levels triggered significantly weaker reactions as the stress persisted, while the mice maintained strong responses to higher decibel sounds. Physiological and behavioral evidence of stress. Left: Schematics of two-photon imaging during baseline and repetitive stress conditions. In repetitive stress sessions, the mice were placed in a 50 ml tube for 30 min to achieve mild stress. The imaging session started directly after the restraint. Individual cells were tracked over imaging days. Shown are examples of 2 imaging planes on day 1 and day 9 (scale bar, 50 μm) and the noise-evoked responses of 3 exemplar cells (mean ± SE). Credit: Bisharat G et al., 2025, PLOS Biology, CC-BY 4.0 A Cellular Shift Under Stress They also discovered that this effect may be driven by one type of inhibitory cell becoming vastly more active under conditions of repeated stress and suppressing other cells. They found that SST cells in the brain began to fire much more strongly when a sound was played whereas the activities of pyramidal and PV cells dropped. That may explain the dampening of sounds, according to Dr. Resnik. Stress May Alter Everyday Sound Perception “Our research suggests that repeated stress doesn’t just impact our reactions to emotionally charged stimuli—it may also alter how we respond to everyday neutral stimuli,” she concluded. Reference: “Repeated stress gradually impairs auditory processing and perception” by Ghattas Bisharat, Ekaterina Kaganovski, Hila Sapir, Anita Temnogorod, Tal Levy and Jennifer Resnik, 11 February 2025, PLOS Biology. DOI: 10.1371/journal.pbio.3003012 Additional researchers included her students: Ghattas Bisharat, Ekaterina Kaganovski, Hila Sapir, Anita Temnogorod, and Tal Levy. Dr. Resnik is also a member of the Zelman Center for Brain Science Research. The research was supported by the Israel Science Foundation (Grant no. 725/21).

DVDV1551RTWW78V